AzTrials
AzTrials

Catheterization, PeripheralNCT04262947

Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

A study testing Near Infrared Vein Imaging and Conventional IV placement in people with Catheterization, Peripheral, run by Lahey Clinic at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in… Read more about this study

Who is it for?
Ages 15 years and olderHealthy volunteers can take part
Conditions the study is for
Catheterization, Peripheral
What is being tested?
Near Infrared Vein Imaging and Conventional IV placement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteUnited States
Study dates
22 Jan 2020to 1 Apr 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • non-pediatric in-hospital patients (≥15 years of age, inpatient and outpatient setting)
  • willing to provide research authorization
  • scheduled and consented to undergo peripheral venous cannulation of one of the upper extremities to be performed by one of the members of the Vascular Access Team
  • determined to be a difficult peripheral venous access defined by one of the following criteria in alignment to the A-DIVA scale to be assessed by one of the members of the Vascular Access Team [8]:
  • failed inspection for more than one visible or palpable suitable vein through conventional methods
  • failed at least one attempt of peripheral venous cannulation through any methods
  • history of difficult peripheral venous access
  • greatest diameter of target vein less than 3mm determined by conventional methods

Who cannot join

  • clinical contraindication for placement of peripheral venous catheter, including:
  • severe bilateral upper extremity edema
  • severe bilateral upper extremity skin burn
  • severe bilateral upper extremity cellulitis
  • history of bilateral axillary lymphadenectomy
  • known severe cardiovascular or pulmonary compromise demanding minimization of procedure time, such as:
Show all 14Show fewer
  • severe shock with severe cardiovascular instability
  • active CPR
  • major uncontrolled hemorrhage
  • any condition for which the primary healthcare provider is requesting emergent venous access
  • scheduled PICC or midline catheter placement
  • non-English-speaking patients if an interpreter is not available
  • prisoner and any individual involuntarily confined or detained in a penal institution
  • impaired capacity to make informed medical decisions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Lahey Clinic

    Burlington, Massachusetts, 01805

Other trials in United States

About this study

Official title: The Efficacy of Near-Infrared Vein Imaging for the Success of Placing Peripheral Venous Catheters in Adults With Difficult Venous Access

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access patients using traditional peripheral venous catheter placement compared to two established methods utilizing NIR vein imaging. The investigators hypothesize that the capability to successfully place lasting peripheral venous catheters is increased with the adjunct of the imaging technology, reducing the number of failed needle sticks, reducing the number of peripheral venous catheters placed throughout a patient's hospital stay, and reducing the need for more invasive catheters such as PICC lines.

Read the detailed description

The efficacy of NIR vein finders beyond the first line approach, particularly in patients that have failed conventional peripheral venous access methods or in patients that are expected to be a "difficult stick", is not established. Conflicting results have been reported in the pediatric literature regarding the subjective benefit of NIR light devices in patients with perceived difficult peripheral intravenous access. In addition, knowledge about the efficacy of these devices in the adult inpatient setting is mostly unknown. The aim of the present study is to address these knowledge gaps.

Being tested
Near Infrared Vein Imaging, Conventional IV placement
Keywords
Near-Infrared Vein Imaging, Difficult Venous Access

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Near Infrared Vein ImagingDevice

    Also called VeinViewer Flex

    Use of NI vein imaging device for visualization of veins during peripheral IV placement

  • Conventional IV placementOther

    IV placement utilizing conventional methods

Study groups in NCT04262947
Study groupRoleWhat they receive
Conventional MethodActive comparatorPlacement of peripheral venous catheter using conventional methods
Receives: Other: Conventional IV placement
VeinViewer Visualization OnlyExperimentalUse of a VeinViewer to visualize the most suitable target. Once the target has been identified and marked, the device will be placed aside and the peripheral venous catheter will be placed using conventional methods
Receives: Device: Near Infrared Vein Imaging; Other: Conventional IV placement
Constant Imaging with VeinViewerExperimentalIdentification of the most suitable target and placement of a peripheral venous catheter under constant imaging with a VeinViewer
Receives: Device: Near Infrared Vein Imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Successful Initial IV Placement

    Rate of successful initial placement of a peripheral venous catheter (investigators have up to 30 minutes or ONE attempt before the study allows for change of technique to the preference of the Vascular Access Team member)

    Measured: up to 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2020
  2. Study start22 Jan 2020
  3. Primary completion1 Apr 2020
  4. Study completion1 Apr 2020

Why it stopped: COVID epidemic

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04262947
Sponsor's protocol ID
20193166
Status last verified
Jan 2022
First submitted
30 Jan 2020
Last updated
4 Mar 2022
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Smith AM, Mancini MC, Nie S. Bioimaging: second window for in vivo imaging. Nat Nanotechnol. 2009 Nov;4(11):710-1. doi: 10.1038/nnano.2009.326.

    PubMed 19898521
  • Kim JG, Xia M, Liu H. Extinction coefficients of hemoglobin for near-infrared spectroscopy of tissue. IEEE Eng Med Biol Mag. 2005 Mar-Apr;24(2):118-21. doi: 10.1109/memb.2005.1411359. No abstract available.

    PubMed 15825855
  • Chiao FB, Resta-Flarer F, Lesser J, Ng J, Ganz A, Pino-Luey D, Bennett H, Perkins C Jr, Witek B. Vein visualization: patient characteristic factors and efficacy of a new infrared vein finder technology. Br J Anaesth. 2013 Jun;110(6):966-71. doi: 10.1093/bja/aet003. Epub 2013 Feb 5.

    PubMed 23384732
  • Guillon P, Makhloufi M, Baillie S, Roucoulet C, Dolimier E, Masquelier AM. Prospective evaluation of venous access difficulty and a near-infrared vein visualizer at four French haemophilia treatment centres. Haemophilia. 2015 Jan;21(1):21-6. doi: 10.1111/hae.12513. Epub 2014 Oct 21.

    PubMed 25335191
  • Park JM, Kim MJ, Yim HW, Lee WC, Jeong H, Kim NJ. Utility of near-infrared light devices for pediatric peripheral intravenous cannulation: a systematic review and meta-analysis. Eur J Pediatr. 2016 Dec;175(12):1975-1988. doi: 10.1007/s00431-016-2796-5. Epub 2016 Oct 26.

    PubMed 27785562
  • Heinrichs J, Fritze Z, Klassen T, Curtis S. A systematic review and meta-analysis of new interventions for peripheral intravenous cannulation of children. Pediatr Emerg Care. 2013 Jul;29(7):858-66. doi: 10.1097/PEC.0b013e3182999bcd.

    PubMed 23823270
  • Johr M, Berger TM. Venous access in children: state of the art. Curr Opin Anaesthesiol. 2015 Jun;28(3):314-20. doi: 10.1097/ACO.0000000000000181.

    PubMed 25827277
  • Loon FHJV, Puijn LAPM, Houterman S, Bouwman ARA. Development of the A-DIVA Scale: A Clinical Predictive Scale to Identify Difficult Intravenous Access in Adult Patients Based on Clinical Observations. Medicine (Baltimore). 2016 Apr;95(16):e3428. doi: 10.1097/MD.0000000000003428.

    PubMed 27100437

Questions about this trial

What is this clinical trial studying?

A study testing Near Infrared Vein Imaging and Conventional IV placement in people with Catheterization, Peripheral, run by Lahey Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 4 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Mar 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Successful Initial IV Placement (time frame: up to 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04262947, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in